International Journal of Breast Cancer / 2015 / Article / Tab 3 / Clinical Study
Quality of Life and Volume Reduction in Women with Secondary Lymphoedema Related to Breast Cancer Table 3 Linear regression model between the score of quality of life at baseline and percentage reduction of excess volume between the upper limb after treatment.
Quality of life Mean (SD) Simple linear regression Beta (CI 95%) valueEORTC QLQ C30 Functional scale Physical function 70.39 (21.39) −0.05 (−0.22–0.12) 0.591 Performing roles 71.16 (33.50) 0.03 (−0.07–0.14) 0.520 Cognitive function 63.43 (28.95) 0.01 (−0.11–0.14) 0.826 Emotional function 54.82 (31.31) −0.05 (−0.17–0.06) 0.388 Social function 89.42 (19.54) −0.01 (−0.20–0.18) 0.917 Symptoms scale Dyspnea 82.70 (33.31) 0.05 (−0.05–0.16) 0.318 Pain 65.72 (35.90) 0.00 (−0.10–0.10) 0.992 Fatigue 68.37 (30.83) −0.03 (−0.15–0.08) 0.563 Insomnia 76.29 (36.29) −0.04 (−0.14–0.05) 0.372 Loss of appetite 92.30 (19.38) 0.01 (−0.17–0.20) 0.878 Nausea and vomiting 92.63 (14.54) 0.09 (−0.16–0.34) 0.486 Constipation 83.33 (31.30) −0.04 (−0.15–0.08) 0.505 Diarrhea 94.87 (19.10) −0.02 (−0.21–0.17) 0.863 Financial hardship 76.94 (38.20) 0.07 (−0.02–0.16) 0.139 Overall quality of life 40.20 (29.18) 0.02 (−0.10–0.15) 0.728 BR23 Functional scale Body image 76.37 (29.02) 0.01 (−0.11–0.14) 0.826 Future perspective 47.28 (40.90) −0.03 (−0.12–0.05) 0.448 Sexual function 76.06 (25.00) 0.00 (−0.14–0.15) 0.951 Symptoms scale Systemic therapy 75.24 (20.23) 0.08 (−0.10–0.25) 0.385 Arm symptoms 53.34 (27.16) −0.11 (−0.24–0.02) 0.099 Breast symptoms 83.49 (21.36) −0.00 (−0.17–0.17) 0.994